日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD

血清干扰素-λ3作为抗MDA5阳性皮肌炎相关间质性肺病疾病控制的短期生物标志物

Kitahara, Yoshihiro; Fujisawa, Tomoyuki; Fukada, Atsuki; Koda, Keigo; Akamatsu, Taisuke; Ikeda, Masaki; Fujii, Masato; Niwa, Mitsuru; Kaida, Yusuke; Matsuda, Hiroyuki; Yokomura, Koshi; Koshimizu, Naoki; Toyoshima, Mikio; Imokawa, Shiro; Hashimoto, Dai; Yamashita, Keita; Iwaizumi, Moriya; Maekawa, Masato; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Karayama, Masato; Furuhashi, Kazuki; Enomoto, Noriyuki; Inui, Naoki; Suda, Takafumi

Simultaneous Resection for Type A Thymoma With Synchronous Solitary Pulmonary Metastasis: A Case Report

A型胸腺瘤合并同步性孤立性肺转移瘤同期切除术:病例报告

Hayakawa, Takamitsu; Mitake, Mikako; Inaba, Hirohisa; Miyamoto, Saita; Masuda, Takuya; Takahashi, Shingo; Fukada, Atsuki; Sugimoto, Ai; Morita, Masako; Matsuda, Hiroyuki; Okabe, Asako; Funai, Kazuhito

Distinct immunity dynamics of natural killer cells in mild and moderate COVID-19 cases during the Omicron variant phase

在 Omicron 变异阶段,轻症和中症 COVID-19 病例中自然杀伤细胞的免疫动力学存在显著差异。

Yukari Nishikawa # ,Kosuke Yamaguchi # ,Ma'arif Athok Shofiudin ,Momone Mimura ,Miyako Takata ,Shu Mihara ,Takeru Kawakami ,Ayumu Doi ,Risa Matsuda ,Hiroyuki Kato ,Ryo Okamoto ,Kengo Mukuda ,Naoki Kinoshita ,Kensaku Okada ,Tsuyoshi Kitaura ,Masaki Nakamoto ,Hisashi Noma ,Yusuke Endo ,Akira Yamasaki ,Hiroki Chikumi

Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective

从日本支付方的角度对非奈利酮治疗2型糖尿病合并慢性肾病患者的成本效益进行分析

Igarashi, Ataru; Ohara, Kenichi; Matsuda, Hiroyuki; Morii, Junko; Jagannathan, Suchitra; Filomeno, Ronald

Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia

分析特发性间质性肺炎患者支气管肺泡灌洗液淋巴细胞比例与自身免疫特征之间的关系

Enomoto, Noriyuki; Watanuki, Masayuki; Nakai, Shogo; Yazawa, Shusuke; Mochizuka, Yasutaka; Fukada, Atsuki; Tanaka, Yuko; Naoi, Hyogo; Inoue, Yusuke; Yasui, Hideki; Karayama, Masato; Suzuki, Yuzo; Hozumi, Hironao; Furuhashi, Kazuki; Toyoshima, Mikio; Kono, Masato; Imokawa, Shiro; Fujii, Masato; Akamatsu, Taisuke; Koshimizu, Naoki; Yokomura, Koshi; Matsuda, Hiroyuki; Kaida, Yusuke; Nakamura, Yutaro; Shirai, Masahiro; Mori, Kazutaka; Masuda, Masafumi; Fujisawa, Tomoyuki; Inui, Naoki; Sugiura, Hiroaki; Sumikawa, Hiromitsu; Kitani, Masashi; Tabata, Kazuhiro; Ogawa, Noriyoshi; Suda, Takafumi

Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia

特发性间质性肺炎患者自身抗体在急性加重风险分层中的应用

Yazawa, Shusuke; Enomoto, Noriyuki; Nakai, Shogo; Mochizuka, Yasutaka; Fukada, Atsuki; Tanaka, Yuko; Naoi, Hyogo; Inoue, Yusuke; Yasui, Hideki; Karayama, Masato; Suzuki, Yuzo; Hozumi, Hironao; Furuhashi, Kazuki; Toyoshima, Mikio; Kono, Masato; Imokawa, Shiro; Fujii, Masato; Akamatsu, Taisuke; Koshimizu, Naoki; Yokomura, Koshi; Matsuda, Hiroyuki; Kaida, Yusuke; Nakamura, Yutaro; Shirai, Masahiro; Mori, Kazutaka; Masuda, Masafumi; Fujisawa, Tomoyuki; Inui, Naoki; Sugiura, Hiroaki; Sumikawa, Hiromitsu; Kitani, Masashi; Tabata, Kazuhiro; Ogawa, Noriyoshi; Suda, Takafumi

Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies

接受免疫检查点抑制剂治疗的晚期非小细胞肺癌患者停药后的生存情况:前瞻性队列研究的汇总分析

Inoue, Yusuke; Kitahara, Yoshihiro; Karayama, Masato; Asada, Kazuhiro; Nishimoto, Koji; Matsuura, Shun; Hashimoto, Dai; Fujii, Masato; Matsui, Takashi; Inami, Nao; Toyoshima, Mikio; Matsuda, Hiroyuki; Ikeda, Masaki; Niwa, Mitsuru; Kaida, Yusuke; Sato, Masaki; Ito, Yasuhiro; Yasui, Hideki; Suzuki, Yuzo; Hozumi, Hironao; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Inui, Naoki; Suda, Takafumi

Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir Compared with Molnupiravir in Patients at High Risk for Progression to Severe COVID-19 in Japan

日本高危COVID-19进展为重症患者中,尼马替韦/利托那韦与莫努匹韦的成本效益分析

Yuasa, Akira; Matsuda, Hiroyuki; Fujii, Yosuke; Mugwagwa, Tendai; Kado, Yuki; Yoshida, Mizuki; Murata, Koichi; Gu, Yoshiaki

Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial

奥氮平联合三联止吐疗法预防卡铂引起的恶心和呕吐:一项随机、双盲、安慰剂对照的III期试验

Inui, Naoki; Suzuki, Takahito; Tanaka, Kazuki; Karayama, Masato; Inoue, Yusuke; Mori, Kazutaka; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Matsuura, Shun; Nishimoto, Koji; Matsui, Takashi; Asada, Kazuhiro; Hashimoto, Dai; Fujii, Masato; Niwa, Mitsuru; Uehara, Masahiro; Matsuda, Hiroyuki; Koda, Keigo; Ikeda, Masaki; Inami, Nao; Tamiya, Yutaro; Kato, Masato; Nakano, Hideki; Mino, Yasuaki; Enomoto, Noriyuki; Suda, Takafumi

Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis

日本抗菌素耐药性负担:系统文献综述和荟萃分析

Matsumoto, Tetsuya; Yuasa, Akira; Matsuda, Hiroyuki; Ainiwaer, Dilinuer; Yonemoto, Naohiro